Thomson Horstmann & Bryant Inc. reduced its stake in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 1.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 361,957 shares of the medical instruments supplier’s stock after selling 5,420 shares during the period. Merit Medical Systems comprises approximately 1.3% of Thomson Horstmann & Bryant Inc.’s portfolio, making the stock its 19th largest position. Thomson Horstmann & Bryant Inc. owned about 0.81% of Merit Medical Systems worth $10,460,000 as of its most recent filing with the SEC.

A number of other hedge funds also recently made changes to their positions in the company. BRYN MAWR TRUST Co raised its stake in shares of Merit Medical Systems by 0.3% in the third quarter. BRYN MAWR TRUST Co now owns 141,954 shares of the medical instruments supplier’s stock valued at $3,448,000 after buying an additional 447 shares in the last quarter. Argent Capital Management LLC raised its stake in shares of Merit Medical Systems by 24.7% in the third quarter. Argent Capital Management LLC now owns 133,175 shares of the medical instruments supplier’s stock valued at $3,235,000 after buying an additional 26,400 shares in the last quarter. Rothschild Asset Management Inc. raised its stake in shares of Merit Medical Systems by 4,258.1% in the third quarter. Rothschild Asset Management Inc. now owns 723,876 shares of the medical instruments supplier’s stock valued at $17,583,000 after buying an additional 707,266 shares in the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Merit Medical Systems by 3.1% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,695,522 shares of the medical instruments supplier’s stock valued at $71,431,000 after buying an additional 80,045 shares in the last quarter. Finally, Bank of Montreal Can raised its stake in shares of Merit Medical Systems by 296.8% in the third quarter. Bank of Montreal Can now owns 266,744 shares of the medical instruments supplier’s stock valued at $6,480,000 after buying an additional 199,512 shares in the last quarter. 91.92% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) remained flat at $29.00 during midday trading on Thursday. 235,285 shares of the company’s stock traded hands. The company has a market capitalization of $1.29 billion, a P/E ratio of 64.44 and a beta of 0.93. The stock’s 50-day moving average is $29.41 and its 200-day moving average is $26.27. Merit Medical Systems, Inc. has a one year low of $18.22 and a one year high of $31.70.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Tuesday, February 21st. The medical instruments supplier reported $0.31 EPS for the quarter, topping the consensus estimate of $0.28 by $0.03. The company earned $157.72 million during the quarter, compared to analyst estimates of $160.39 million. Merit Medical Systems had a net margin of 3.25% and a return on equity of 8.85%. Merit Medical Systems’s quarterly revenue was up 14.0% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.24 earnings per share. On average, equities research analysts forecast that Merit Medical Systems, Inc. will post $1.13 earnings per share for the current fiscal year.

TRADEMARK VIOLATION WARNING: This story was posted by Watch List News and is the sole property of of Watch List News. If you are viewing this story on another site, it was illegally copied and reposted in violation of international copyright laws. The original version of this story can be viewed at http://www.watchlistnews.com/thomson-horstmann-bryant-inc-decreases-stake-in-merit-medical-systems-inc-mmsi/1205812.html.

MMSI has been the topic of several research reports. Canaccord Genuity reaffirmed a “buy” rating and issued a $35.00 price objective on shares of Merit Medical Systems in a research report on Monday, February 27th. Zacks Investment Research raised shares of Merit Medical Systems from a “hold” rating to a “strong-buy” rating and set a $34.00 price target on the stock in a research report on Friday, February 24th. Piper Jaffray Companies reissued an “overweight” rating on shares of Merit Medical Systems in a research report on Wednesday, March 29th. Craig Hallum initiated coverage on shares of Merit Medical Systems in a research report on Monday. They issued a “buy” rating and a $36.00 price target on the stock. Finally, Wells Fargo & Co initiated coverage on shares of Merit Medical Systems in a research report on Wednesday, April 5th. They issued an “outperform” rating and a $31.70 price target on the stock. Two analysts have rated the stock with a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average price target of $31.04.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

5 Day Chart for NASDAQ:MMSI

Want to see what other hedge funds are holding MMSI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merit Medical Systems, Inc. (NASDAQ:MMSI).

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.